Skip to main content

Open Label Extension study of Rozanolixizumab in CIDP

Clinical Trial Grant
Duke Scholars

Administered By

Neurology, Neuromuscular Disease

Awarded By

UCB Biopharma SPRL

Start Date

December 7, 2020

End Date

September 6, 2022
 

Administered By

Neurology, Neuromuscular Disease

Awarded By

UCB Biopharma SPRL

Start Date

December 7, 2020

End Date

September 6, 2022